Loading…
Disease Activity in Psoriatic Arthritis : Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World
Objective. To compare, “in a real world,” the performance of the most common composite activity indices in a cohort of PsA patients. Methods. A total of 171 PsA patients were involved. The following variables were evaluated: peripheral joint assessment, patient reported of pain, physician and patien...
Saved in:
Published in: | BioMed research international 2014-01, Vol.2014 (2014), p.1-12 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013 |
---|---|
cites | cdi_FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013 |
container_end_page | 12 |
container_issue | 2014 |
container_start_page | 1 |
container_title | BioMed research international |
container_volume | 2014 |
creator | Salaffi, Fausto Ciapetti, Alessandro Carotti, Marina Gasparini, Stefania Gutierrez, Marwin |
description | Objective. To compare, “in a real world,” the performance of the most common composite activity indices in a cohort of PsA patients. Methods. A total of 171 PsA patients were involved. The following variables were evaluated: peripheral joint assessment, patient reported of pain, physician and patient assessments of disease activity, patient general health status, dactylitis digit count, Leeds Enthesitis Index, Health Assessment Questionnaire (HAQ), physical and mental component summary score of the Medical Outcome Survey (SF-36), Psoriasis Area and Severity Index (PASI), Dermatology Life Quality Index, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). To measure the disease activity, the Disease Activity Score (DAS28-ESR and DAS28-CRP), Simple Disease Activity Index (SDAI), Composite Psoriatic Disease Activity Index (CPDAI), disease activity in psoriatic arthritis (DAPSA), and Psoriatic Arthritis Disease Activity Score (PASDAS) have been calculated. The criteria for minimal disease activity (MDA) and remission were applied as external criterion. Results. The ROC were similar in all the composite measures. Only the CPDAI showed less discriminative ability. There was a high degree of correlation between all the indices (P |
doi_str_mv | 10.1155/2014/528105 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4055291</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A427023436</galeid><sourcerecordid>A427023436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013</originalsourceid><addsrcrecordid>eNqN0stu1DAUBuAIgWhVumINssQGgYb6GjtdII2GW6VKIK5Ly2OfdFxl7MF2BvocvDAOU4bLBrJJnHz-bZ-cprlL8BNChDihmPATQRXB4kZzSBnhs5ZwcnP_zNhBc5zzJa6XIi3u2tvNAeVdK5kUh823Zz6DyYDmtvitL1fIB_Qmx-RN8RbNU1klX3xGp2gR1xuTfI4BxR6VFaA61ya_9qHaLaCF2Rg7RZjgqg65pNEW9NEM3k2v66x3_uuPnJh9AXQWnLeQpyUNegtmQJ9iGtyd5lZvhgzH1_ej5sOL5-8Xr2bnr1-eLebnMyuoLDPBKGk7qeiSK0exdbgOJHAnuVGqA4WhU1JQ7EwVlC6BLXusWky5MAQTdtQ83eVuxuUanIVQkhn0ph7JpCsdjdd_fgl-pS_iVnMsBO2mgIfXASl-HiEXva4VgWEwAeKYNRFtq4SUnfoPygmTWHa80gd_0cs4plArMSnZUV5_7S91YQbQPvSxbtFOoXrOqcSUcdZW9XinbIo5J-j3pyNYTw2kpwbSuwaq-v7vBdnbn-1SwaMdWPngzBf_j7R7OwyVQG_2mEulhGLfAXvc1S4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547924231</pqid></control><display><type>article</type><title>Disease Activity in Psoriatic Arthritis : Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World</title><source>Wiley Online Library Open Access</source><source>Publicly Available Content Database</source><creator>Salaffi, Fausto ; Ciapetti, Alessandro ; Carotti, Marina ; Gasparini, Stefania ; Gutierrez, Marwin</creator><contributor>Nanki, Toshihiro</contributor><creatorcontrib>Salaffi, Fausto ; Ciapetti, Alessandro ; Carotti, Marina ; Gasparini, Stefania ; Gutierrez, Marwin ; Nanki, Toshihiro</creatorcontrib><description>Objective. To compare, “in a real world,” the performance of the most common composite activity indices in a cohort of PsA patients. Methods. A total of 171 PsA patients were involved. The following variables were evaluated: peripheral joint assessment, patient reported of pain, physician and patient assessments of disease activity, patient general health status, dactylitis digit count, Leeds Enthesitis Index, Health Assessment Questionnaire (HAQ), physical and mental component summary score of the Medical Outcome Survey (SF-36), Psoriasis Area and Severity Index (PASI), Dermatology Life Quality Index, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). To measure the disease activity, the Disease Activity Score (DAS28-ESR and DAS28-CRP), Simple Disease Activity Index (SDAI), Composite Psoriatic Disease Activity Index (CPDAI), disease activity in psoriatic arthritis (DAPSA), and Psoriatic Arthritis Disease Activity Score (PASDAS) have been calculated. The criteria for minimal disease activity (MDA) and remission were applied as external criterion. Results. The ROC were similar in all the composite measures. Only the CPDAI showed less discriminative ability. There was a high degree of correlation between all the indices (P<0.0001). The highest correlations were between DAPSA and SDAI (rho = 0.996) and between DAPSA and DAS28-CRP (rho = 0.957). CPDAI, DAPSA, and PASDAS had the most stringent definitions of remission and MDA category. DAS28-ESR and DAS28-CRP had the highest proportions in remission and MDA. Conclusions. Although a good concurrent validity and discriminant capacity of six disease activity indices were observed, the proportions of patients classified in the disease activity levels differed. In particular, the rate of patients in remission was clearly different among the respective indices.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2014/528105</identifier><identifier>PMID: 24967375</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Puplishing Corporation</publisher><subject>Adult ; Arthritis, Psoriatic - pathology ; Arthritis, Psoriatic - physiopathology ; Arthritis, Psoriatic - therapy ; Care and treatment ; Clinical trials ; Comparative analysis ; Development and progression ; Diagnosis ; Female ; Humans ; Male ; Middle Aged ; Outcome and process assessment (Health Care) ; Patients ; Psoriasis ; Psoriatic arthritis ; Quality of life ; Questionnaires ; Remission (Medicine) ; Remission Induction ; Rheumatology ; Severity of Illness Index ; Skin diseases ; Sociodemographics ; Variables</subject><ispartof>BioMed research international, 2014-01, Vol.2014 (2014), p.1-12</ispartof><rights>Copyright © 2014 Fausto Salaffi et al.</rights><rights>COPYRIGHT 2014 John Wiley & Sons, Inc.</rights><rights>Copyright © 2014 Fausto Salaffi et al. Fausto Salaffi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2014 Fausto Salaffi et al. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013</citedby><cites>FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013</cites><orcidid>0000-0002-7995-1110 ; 0000-0002-3224-1760</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1547924231/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1547924231?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24967375$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Nanki, Toshihiro</contributor><creatorcontrib>Salaffi, Fausto</creatorcontrib><creatorcontrib>Ciapetti, Alessandro</creatorcontrib><creatorcontrib>Carotti, Marina</creatorcontrib><creatorcontrib>Gasparini, Stefania</creatorcontrib><creatorcontrib>Gutierrez, Marwin</creatorcontrib><title>Disease Activity in Psoriatic Arthritis : Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Objective. To compare, “in a real world,” the performance of the most common composite activity indices in a cohort of PsA patients. Methods. A total of 171 PsA patients were involved. The following variables were evaluated: peripheral joint assessment, patient reported of pain, physician and patient assessments of disease activity, patient general health status, dactylitis digit count, Leeds Enthesitis Index, Health Assessment Questionnaire (HAQ), physical and mental component summary score of the Medical Outcome Survey (SF-36), Psoriasis Area and Severity Index (PASI), Dermatology Life Quality Index, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). To measure the disease activity, the Disease Activity Score (DAS28-ESR and DAS28-CRP), Simple Disease Activity Index (SDAI), Composite Psoriatic Disease Activity Index (CPDAI), disease activity in psoriatic arthritis (DAPSA), and Psoriatic Arthritis Disease Activity Score (PASDAS) have been calculated. The criteria for minimal disease activity (MDA) and remission were applied as external criterion. Results. The ROC were similar in all the composite measures. Only the CPDAI showed less discriminative ability. There was a high degree of correlation between all the indices (P<0.0001). The highest correlations were between DAPSA and SDAI (rho = 0.996) and between DAPSA and DAS28-CRP (rho = 0.957). CPDAI, DAPSA, and PASDAS had the most stringent definitions of remission and MDA category. DAS28-ESR and DAS28-CRP had the highest proportions in remission and MDA. Conclusions. Although a good concurrent validity and discriminant capacity of six disease activity indices were observed, the proportions of patients classified in the disease activity levels differed. In particular, the rate of patients in remission was clearly different among the respective indices.</description><subject>Adult</subject><subject>Arthritis, Psoriatic - pathology</subject><subject>Arthritis, Psoriatic - physiopathology</subject><subject>Arthritis, Psoriatic - therapy</subject><subject>Care and treatment</subject><subject>Clinical trials</subject><subject>Comparative analysis</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Outcome and process assessment (Health Care)</subject><subject>Patients</subject><subject>Psoriasis</subject><subject>Psoriatic arthritis</subject><subject>Quality of life</subject><subject>Questionnaires</subject><subject>Remission (Medicine)</subject><subject>Remission Induction</subject><subject>Rheumatology</subject><subject>Severity of Illness Index</subject><subject>Skin diseases</subject><subject>Sociodemographics</subject><subject>Variables</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqN0stu1DAUBuAIgWhVumINssQGgYb6GjtdII2GW6VKIK5Ly2OfdFxl7MF2BvocvDAOU4bLBrJJnHz-bZ-cprlL8BNChDihmPATQRXB4kZzSBnhs5ZwcnP_zNhBc5zzJa6XIi3u2tvNAeVdK5kUh823Zz6DyYDmtvitL1fIB_Qmx-RN8RbNU1klX3xGp2gR1xuTfI4BxR6VFaA61ya_9qHaLaCF2Rg7RZjgqg65pNEW9NEM3k2v66x3_uuPnJh9AXQWnLeQpyUNegtmQJ9iGtyd5lZvhgzH1_ej5sOL5-8Xr2bnr1-eLebnMyuoLDPBKGk7qeiSK0exdbgOJHAnuVGqA4WhU1JQ7EwVlC6BLXusWky5MAQTdtQ83eVuxuUanIVQkhn0ph7JpCsdjdd_fgl-pS_iVnMsBO2mgIfXASl-HiEXva4VgWEwAeKYNRFtq4SUnfoPygmTWHa80gd_0cs4plArMSnZUV5_7S91YQbQPvSxbtFOoXrOqcSUcdZW9XinbIo5J-j3pyNYTw2kpwbSuwaq-v7vBdnbn-1SwaMdWPngzBf_j7R7OwyVQG_2mEulhGLfAXvc1S4</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Salaffi, Fausto</creator><creator>Ciapetti, Alessandro</creator><creator>Carotti, Marina</creator><creator>Gasparini, Stefania</creator><creator>Gutierrez, Marwin</creator><general>Hindawi Puplishing Corporation</general><general>Hindawi Publishing Corporation</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7995-1110</orcidid><orcidid>https://orcid.org/0000-0002-3224-1760</orcidid></search><sort><creationdate>20140101</creationdate><title>Disease Activity in Psoriatic Arthritis : Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World</title><author>Salaffi, Fausto ; Ciapetti, Alessandro ; Carotti, Marina ; Gasparini, Stefania ; Gutierrez, Marwin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Arthritis, Psoriatic - pathology</topic><topic>Arthritis, Psoriatic - physiopathology</topic><topic>Arthritis, Psoriatic - therapy</topic><topic>Care and treatment</topic><topic>Clinical trials</topic><topic>Comparative analysis</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Outcome and process assessment (Health Care)</topic><topic>Patients</topic><topic>Psoriasis</topic><topic>Psoriatic arthritis</topic><topic>Quality of life</topic><topic>Questionnaires</topic><topic>Remission (Medicine)</topic><topic>Remission Induction</topic><topic>Rheumatology</topic><topic>Severity of Illness Index</topic><topic>Skin diseases</topic><topic>Sociodemographics</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salaffi, Fausto</creatorcontrib><creatorcontrib>Ciapetti, Alessandro</creatorcontrib><creatorcontrib>Carotti, Marina</creatorcontrib><creatorcontrib>Gasparini, Stefania</creatorcontrib><creatorcontrib>Gutierrez, Marwin</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Database (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salaffi, Fausto</au><au>Ciapetti, Alessandro</au><au>Carotti, Marina</au><au>Gasparini, Stefania</au><au>Gutierrez, Marwin</au><au>Nanki, Toshihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Disease Activity in Psoriatic Arthritis : Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>2014</volume><issue>2014</issue><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Objective. To compare, “in a real world,” the performance of the most common composite activity indices in a cohort of PsA patients. Methods. A total of 171 PsA patients were involved. The following variables were evaluated: peripheral joint assessment, patient reported of pain, physician and patient assessments of disease activity, patient general health status, dactylitis digit count, Leeds Enthesitis Index, Health Assessment Questionnaire (HAQ), physical and mental component summary score of the Medical Outcome Survey (SF-36), Psoriasis Area and Severity Index (PASI), Dermatology Life Quality Index, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). To measure the disease activity, the Disease Activity Score (DAS28-ESR and DAS28-CRP), Simple Disease Activity Index (SDAI), Composite Psoriatic Disease Activity Index (CPDAI), disease activity in psoriatic arthritis (DAPSA), and Psoriatic Arthritis Disease Activity Score (PASDAS) have been calculated. The criteria for minimal disease activity (MDA) and remission were applied as external criterion. Results. The ROC were similar in all the composite measures. Only the CPDAI showed less discriminative ability. There was a high degree of correlation between all the indices (P<0.0001). The highest correlations were between DAPSA and SDAI (rho = 0.996) and between DAPSA and DAS28-CRP (rho = 0.957). CPDAI, DAPSA, and PASDAS had the most stringent definitions of remission and MDA category. DAS28-ESR and DAS28-CRP had the highest proportions in remission and MDA. Conclusions. Although a good concurrent validity and discriminant capacity of six disease activity indices were observed, the proportions of patients classified in the disease activity levels differed. In particular, the rate of patients in remission was clearly different among the respective indices.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Puplishing Corporation</pub><pmid>24967375</pmid><doi>10.1155/2014/528105</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-7995-1110</orcidid><orcidid>https://orcid.org/0000-0002-3224-1760</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2314-6133 |
ispartof | BioMed research international, 2014-01, Vol.2014 (2014), p.1-12 |
issn | 2314-6133 2314-6141 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4055291 |
source | Wiley Online Library Open Access; Publicly Available Content Database |
subjects | Adult Arthritis, Psoriatic - pathology Arthritis, Psoriatic - physiopathology Arthritis, Psoriatic - therapy Care and treatment Clinical trials Comparative analysis Development and progression Diagnosis Female Humans Male Middle Aged Outcome and process assessment (Health Care) Patients Psoriasis Psoriatic arthritis Quality of life Questionnaires Remission (Medicine) Remission Induction Rheumatology Severity of Illness Index Skin diseases Sociodemographics Variables |
title | Disease Activity in Psoriatic Arthritis : Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A52%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Disease%20Activity%20in%20Psoriatic%20Arthritis%20:%20Comparison%20of%20the%20Discriminative%20Capacity%20and%20Construct%20Validity%20of%20Six%20Composite%20Indices%20in%20a%20Real%20World&rft.jtitle=BioMed%20research%20international&rft.au=Salaffi,%20Fausto&rft.date=2014-01-01&rft.volume=2014&rft.issue=2014&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2014/528105&rft_dat=%3Cgale_pubme%3EA427023436%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1547924231&rft_id=info:pmid/24967375&rft_galeid=A427023436&rfr_iscdi=true |